Best Friends breast augmentation (2 people) package Turkey

Two travellers, two separate clinical assessments

Plastic Surgery Turkey can coordinate travel logistics for friends, but it does not combine their diagnoses or treatment decisions. Each traveller needs an individual breast assessment covering tissue, implant options where relevant, health history and surgical suitability.

Each person supplies their own medical history, medicines and consent, and may receive a different recommendation after assessment.

Planning shared travel without shared medical assumptions

Friends may share hotel and transfers, while procedure dates and recommendations remain individual after each assessment.

Arrival dates, procedure days and reviews can be coordinated only where they remain compatible with each person's clinical plan.

Recovery support with individual restrictions

Each person follows their own breast-surgery restrictions and must plan separate support, medication and review needs.

Friends can assist with practical arrangements, but neither should act as the other's clinical substitute or ignore their own discharge advice.

Two written scopes, not one assumed treatment

Request two separate breast-surgery quotes, each with its own procedure scope, implant-related items where relevant and follow-up.

Ask for a separate itemised quote, consent process and follow-up plan for each traveller, including any shared hotel or transfer arrangement.

Questions from you

These questions help you ask a hospital or clinic for a clear written treatment plan. They do not promise a particular method, device, follow-up arrangement or payment responsibility. Plastic Surgery Turkey is an independent information, marketing and enquiry platform, not a healthcare provider or medical-tourism intermediary. With your consent, an enquiry may be shared with an authorised healthcare partner.

What implant will be used, and will I receive an implant card?

For legally marketed breast implants, the FDA expects labelling that identifies device materials and a patient device card that can identify the implant after surgery. Products may contain saline or silicone gel and differ in shape, style and surface, including smooth or textured options. The written surgical plan should choose volume and profile using breast-base width, tissue cover and the projection discussed with the patient; this page does not recommend a brand. For approved saline implants, the FDA does not recommend an umbilical incision because of rupture risk. Sources: FDA points to consider before breast implants, FDA breast implant risks.

What long-term imaging plan applies to silicone implants, alongside routine breast screening?

Breast implants are not lifetime devices, and later removal or replacement may be needed. Saline deflation is often visible; a silicone rupture can be silent and may not be found by examination alone. The FDA describes MRI as the most effective method for detecting silent silicone rupture and accepts ultrasound as a screening alternative for people without symptoms. Its labelling guidance suggests the first ultrasound or MRI at 5–6 years and then every 2–3 years for asymptomatic silicone-gel implant patients; symptoms or an unclear ultrasound may call for MRI. This surveillance is separate from mammography for breast-cancer screening, and later costs should be discussed separately. Sources: FDA breast implant risks, FDA breast implant labeling guidance, and American Society of Plastic Surgeons implant-safety guidance.

How would capsular contracture, rupture, displacement or a rare implant-associated disease be recognised?

Capsular contracture is tightening of the scar capsule around an implant. FDA Baker grades run from I, soft and natural, to II, firmer but natural, III, firm and distorted, and IV, firm, painful and distorted; grades III and IV often need another operation and can recur after correction. Displacement can occur at surgery or later, with gravity, trauma or the capsule contributing. Saline rupture usually causes loss of size or shape. Silicone rupture may present with smaller size, shape change, firm lump, asymmetry, pain, numbness or swelling, or no symptom. BIA-ALCL is not breast cancer: persistent swelling, pain or another change needs examination, imaging and sometimes fluid or tissue tests. Confirmed disease usually requires implant and capsule removal, sometimes with chemotherapy or radiotherapy. FDA separately tracks SCC and other lymphomas in the capsule. Fatigue, brain fog and joint pain are sometimes called breast implant illness, but its cause is unclear and removal cannot promise resolution. Source: FDA breast implant risks.

Which incision is planned for my anatomy, and how much asymmetry can remain?

The FDA defines asymmetry as a difference in breast size, shape or level, and a difference already present may not disappear completely. For augmentation, the written plan should identify the incision, implant pocket and expected scar location. FDA does not recommend a navel incision for approved saline implants because of rupture and deflation. In an exchange, the new incision commonly uses the old scar, whose position, thin tissue and capsule can limit the choice. Scars are permanent and may widen; a future scar revision should not be assumed to be included in the first fee. Source: FDA breast implant risks.

If an implant or wound problem appears after I return home, who follows it and which costs are whose?

The NHS notes that an overseas clinic may not have the same follow-up duty as a UK surgeon and a doctor may not be arranged in the patient’s own country. Before surgery, put the complication route, review location, return-travel cost and possible further-surgery cost in writing; travel insurance usually excludes surgical complications, and provider insurance is a separate question. FDA notes removal or replacement may not be insured even after a complication. A device card or warranty does not pay the surgeon’s fee, wound care, admission or revision. Ask for the scope to be separated in writing. Increasing swelling or bruising, fever, wound opening, visible implant material, or a new one-sided lump or fluid should be reported without delay. This page promises no partner payment. Sources: NHS advice on cosmetic surgery abroad, FDA points to consider before breast implants.